Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma
Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma
Active, not recruiting · NCT04722575 · Registry updated 2026-06-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Phase 2 | 2026-06-18 | NCT04722575 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Clinical Research Technology S.r.l. | 8 |
| Fondazione Melanoma Onlus | 3 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fondazione I.R.C.C.S. Istituto Nazionale dei Tumori | Milan | Italy | 2 |
| IRCCS - Istituto Scientifico Romagnolo per la Cura e lo Studio dei Tumori (I.R.S.T) S.r.l. | Meldola | Italy | 2 |
| IRCCS San Martino - IST | Genova | Italy | 1 |
| Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale" | Naples | Italy | 2 |
| Istituto Oncologico Veneto | Padova | Italy | 3 |
| Ospedale S.M. Annunziata - Azienda USL Toscana Centro | Bagno a Ripoli | Italy | 2 |